In tissue culture phosphonoacetic acid (PAA) specifically inhibited DNA synthesis of human cytomegalovirus (CMV), murine CMV, simian CMV, Epstein-Barr virus, and Herpesvirus saimiri. Fifty to one hundred micrograms per milliliter PAA completely inhibited viral DNA synthesis with no significant damage to host cell DNA synthesis. In vitro DNA polymerization assays showed that 10 gg/ml of PAA specifically inhibited partially purified human CMVinduced DNA polymerase, while little inhibition of host-cell DNA polymerase activity was found. The specific inhibition of herpes-group virus DNA synthesis with little toxicity to host cells suggests that PAA has great potential as an antiherpesvirus therapeutic agent.
Phosphonoacetic acid (PAA) has been shown to be a very active compound against herpes simplex dermititis in mice and herpes simplex keratitis in rabbits (l1). In tissue culture replication of herpes simplex virus and viral DNA are impeded by PAA while host-cell function remains unharmed. In a study with partially purified herpes simplex virus-induced DNA polymerase, Mao et al. (7) demonstrated that the inhibition involved direct interaction between the compound and the virus-induced DNA polymerase.
We report here similar observations. PAA preferentially inhibited the replication of DNA of human CMV, murine CMV, simian CMV, Epstein-Barr virus, and H. saimiri. Also, DNA polymerases isolated from human CMV-infected human fibroblast (WI-38) were partially purified, and the effect of PAA on the activity of these enzymes was studied in vitro. Figure 1 shows that PAA inhibits human CMV DNA synthesis in virus-infected WI-38 cells. These cells in Falcon flask (75 cm2, No. 3024) were infected with human CMV (strain AD-169) at the multiplicity of 1-2 PFU. After virus absorption, PAA was added at various concentrations. At various intervals after infection the virusinfected or mock-infected cells were lysed with 1% sodium dodecyl sulfate buffer (1% sodium lauryl sulfate, 0.01 M Tris-HCI, pH 7.8, and 0.01 M EDTA) in order to quantitate viral DNA. The total DNA was extracted, and hybridization with CMVspecific [3H] cRNA was carried out as previously described (4) . Human CMV DNA synthesis was completely inhibited in the presence of 50 ,g/ml of PAA. The minimum dose necessary for inhibition was between 20 and 50 ,ug/ml.
The effect of PAA on host-cell DNA synthesis (Fig. 2 ) was measured as previously described (3) by the incorporation of [3H]thymidine into acid-insoluble material from mock-infected cells treated with PAA before confluent monolayers had formed. Partial inhibition of WI-38 DNA synthesis was observed with concentrations of PAA between 100 and 1000 ,ug/ml. At a concentration of 100 mg/ml only 15% of host DNA synthesis was inhibited; whereas viral DNA synthesis was completely inhibited was added to human CMV-infected cell cultures after virus absorption. At various times after infection, the DNA was extracted from the cell cultures for virus genome quantitation by 3H-labeled cRNA-DNA membrane hybridization. Fifty micrograms of DNA and 1.2 x 105 cpm CMV-specific [3H] cRNA (sp act I x 107 cpm/Ag) were applied to each filter. The nucleic acid hybridization was carried out as described previously (4) . at this dose. Even at the highest dose of PAA tested, 1000 gg/ml, cell DNA synthesis was 30% of DNA synthesis in untreated cultures. No obvious morphological alteration was observed in confluent cells in the presence of up to 1000,ug/ml of PAA. This compound has less effect on the confluent cells than on cells in the log phase of growth.
The effect of PAA on partially purified host cell and virus-induced DNA polymerase activity is shown in Fig. 3 . Two large molecular weight host-cell DNA 3, 3a (2) were used in this experiment. A remarkably preferential inhibition of virus-induced DNA polymerase was observed when 10 ,g/ml PAA was added to the reaction mixture; more complete inhibition was obtained when the PAA concentration reached the level of 50,ug/ml. However, host-cell enzymes were relatively resistant to PAA, even at a concentration of 200 ,ug/ml. Evidently the selective inhibition of virus-induced DNA polymerase by PAA accounts for the inhibition of viral DNA synthesis in PAA treated virus-infected cells. Also, PAA appears to interact directly with the virus-induced DNA polymerase and not with the DNA (3) .
The study of the effect of PAA on virus DNA synthesis was also extended to nonhuman CMVs (mouse and simian), cultured in mouse embryo cells and WI-38 cells, respectively, and H. saimiri cultured in owl-monkey kidney cells. In all of these cases PAA also inhibited viral DNA synthesis almost totally (Figs. 4 and 5) . Mouse embryo cells and owl-monkey kidney cells are more resistant to PAA than WI-38 cells. In the presence of 1000 ,g/ml of PAA, the mouse embryo and owl-monkey kidney cell DNA synthesis was still 38 to 42% of that in untreated cultures. H. saimiri, isolated from squirrel monkey (8) , is highly oncogenic. It invariably causes lethal lymphatic leukemia or malignant lymphoma in nonhuman primates (8) .
Finally, the effect of PAA on Epstein-Barr virus (EBV) was studied using the HR1K cell line, an EBV virus-producing Burkitt's lymphoblastoid cell line. The drug was added to the suspension culture at 100 Ag/ml. During the experimental period, the cells were subcultured twice a week in RPMI with 15% fetal calf serum and 100 ,ug/ml of PAA. As shown in Fig. 6 , in 1 week the EBV DNA content was dramatically reduced from 450 genome equivalents per cell to 27 genomes, and continued to decline to 4.5 genomes after 4 weight enzyme (DNA polymerase A) was resistant to PAA, while the large molecular weight DNA polymerase a and polymerase -y were sensitive to PAA. Fifty micrograms per milliliter of PAA inhibited more than 90% of the activity of polymerases a and y and in vitro assay (manuscript in preparation). We have also observed the effect of PAA on EBV DNA synthesis in nonproducing Raji lymphoblastoid line, which contains 60 EBV genome equivalents per cell (9) . There was no reduction in the number of EBV genome equivalents per cell in Raji cells treated with 100 ,g/ml of PAA. This indicated that the mechanism of EBV DNA replication in nonproducing Raji cells might be different from that in producing HR 1 K cells. More experiments are in progress.
The specific inhibition of herpes-group virus DNA synthesis with no or little toxicity to host cells suggests the PAA has great potential as an anti-herpes-group virus therapeutic agent.
